HBV-IN-15
HBV-IN-15 is a potent inhibitor of covalently closed circular DNA (cccDNA) . cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-15 is a flavone derivative. HBV-IN-16 has the potential for the research of HBV infection (extracted from patent WO2020052774A1, compound 2) [1].
Product Specifications
CAS Number
[2413192-50-2]
UNSPSC
12352005
Target
DNA/RNA Synthesis; HBV
Type
Reference compound
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hbv-in-15.html
Solubility
10 mM in DMSO
Smiles
O=C1C=C(C2=CC=C(OCCOC3CC(C3)C(OCC)=O)C=C2)OC4=C1C=CC=C4Cl
Molecular Formula
C24H23ClO6
Molecular Weight
442.89
References & Citations
[1]Dongdong Chen, et al. Flavone derivatives for the treatment and prophylaxis of hepatitis b virus disease. Patent WO2020052774A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
SPTLC1, CT (Serine Palmitoyltransferase 1, Long Chain Base Biosynthesis Protein 1, LCB 1, Serine-palmitoyl-CoA Transferase 1, SPT 1, SPT1, LCB1) (PE) discontinued
MRPS2 (28S Ribosomal Protein S2, Mitochondrial, Mitochondrial Ribosomal Protein S2)
![Wilms Tumor Protein [SC06-41] Antibody](https://cdn.genprice.uk/genprice/uk/genprice2.webp)